(Unlearned) lessons from John Graunt and Kenneth Rothman: A "CLASSic" example

Saved in:

Bibliographic Details
Published in:	Clinical Therapeutics vol. 25, no. 11 (Nov 2003), p. 2891
Main Author:	Arellano, Felix M.
Corporate Author:	Class
Other Authors:	Castellsague, Jordi
Published:	Elsevier Limited
Subjects:	Anti-Inflammatory Agents, Non-Steroidal > adverse effects Data Interpretation, Statistical Endpoint Determination Epidemiologic Methods Epidemiologic Research Design Humans Peptic Ulcer > chemically induced Randomized Controlled Trials as Topic
Online Access:	Citation/Abstract Full Text Full Text - PDF
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Abstract:	This commentary reviews the work of John Graunt and Kenneth J. Rothman on statistical significance and the need for prespecification of study end points. The authors argue that it is dangerous to substitute oversimplifications based exclusively on whether a result has reached statistical significance for a rational process of causal inference. An example is given based on the Celecoxib Lonngterm Arthritis Safety Study. This commentary reviews the work of John Graunt and Kenneth J. Rothman on statistical significance and the need for prespecification of study end points. The authors argue that it is dangerous to substitute oversimplifications based exclusively on whether a result has reached statistical significance for a rational process of causal inference. An example is given based on the Celecoxib Long-term Arthritis Safety Study.
ISSN:	0149-2918 1879-114X
DOI:	10.1016/S0149-2918(03)80341-7
Source:	Healthcare Administration Database